Otros idiomas DRI Healthcare Trust

Acciones

DHT.U

CA23344H1091

Farmacéuticos

Mercado cerrado - Toronto S.E. Otros sitios de cotización 21:59:29 10/12/2024			Varia. Cinco días.	Varia. 1 de enero.
12,13 ^CAD	+0,25 %		-9,48 %	-2,80 %

07/11	DRI Healthcare Trust, Q3 2024 Earnings Call, Nov 07, 2024
06/11	DRI Healthcare Trust presenta los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

DRI Healthcare Trust Brief: National Bank Notes "Attractive valuation on the base portfolio alone"	08/11
DRI Healthcare Trust Brief: Keeps Outperform and Target Raised To C$19.50 From $18.50 at National Bank On Q3 Results	08/11
HLS Therapeutics Brief: Q3 2024 revenue was US$14.1 million	07/11
DRI Healthcare Trust Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	06/11
DRI Healthcare Trust Reports Third Quarter 2024 Results	06/11
DRI Healthcare Trust Declares Fourth Quarterly Cash Distribution, Payable on January 20, 2025	06/11
DRI Healthcare Trust Reports Impairment Charges for the Third Quarter Ended September 30, 2024	06/11
Tranche Update on DRI Healthcare Trust (TSX:DHT.UN)'s Equity Buyback Plan announced on November 13, 2023.	06/11
KalVista Pharmaceuticals Shares Rise 11% on Royalty Financing Deal, Stock Offering	04/11
KalVista Closes Royalty Financing Deal with DRI Healthcare, Prices $55 Million Offering	04/11
DRI Healthcare Trust Acquires Royalty Stake in Global Sales of Sebetralstat	04/11
DRI Healthcare Trust Brief: Announcing Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat	04/11
DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals	04/11
DRI Healthcare Trust Upsizes US$631.6 Million Credit Facilities	01/11
DRI Healthcare Trust Announces Upsized $631.6 Million Credit Facilities	01/11
DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities	01/11
Editas Medicine, Inc. Announces Progress Towards 2024 Goals, Including Achievement of in Vivo Preclinical Proof of Concept	22/10
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 7, 2024	11/10
National Bank on DRI Healthcare's Casgevy Stream Acquisition	04/10
Toronto Stocks Advance; SilverCrest Rises on $1.7 Billion Acquisition by Coeur Mining	04/10
DRI Healthcare Trust Buying Payment Streams Based On Gene-Editing Technology For US$57 Million	04/10
Editas Medicine Sells Future License Fees for Gene-Editing Technology for $57 Million	04/10
DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)	04/10
DRI Healthcare Trust(TSX:DHT.UN) added to S&P Global BMI Index	23/09
HLS Therapeutics Q2 Net Loss Narrows With Cut in Expenses, Revenue Falls	08/08

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas DRI Healthcare Trust

Acciones

DHT.U

CA23344H1091

Farmacéuticos

Otros idiomas

Filtros